AAAAAA

   
Results: 1-17 |
Results: 17

Authors: Gill, JK Wang, LJ Bretner, M Newman, R Kyprianou, N Hosmane, RS
Citation: Jk. Gill et al., Potent in vitro anticancer activities of ring-expanded ("fat") nucleosidescontaining the imidazo[4,5-E][1,3]diazepine ring system, NUCLEOS NUC, 20(4-7), 2001, pp. 1043-1045

Authors: Keledjian, K Borkowski, A Kim, G Isaacs, JT Jacobs, SC Kyprianou, N
Citation: K. Keledjian et al., Reduction of human prostate tumor vascularity by the alpha 1-adrenoceptor antagonist terazosin, PROSTATE, 48(2), 2001, pp. 71-78

Authors: Glassman, DT Chon, JK Borkowski, A Jacobs, SC Kyprianou, N
Citation: Dt. Glassman et al., Combined effect of terazosin and finasteride on apoptosis, cell proliferation, and transforming growth factor-beta expression in benign prostatic hyperplasia, PROSTATE, 46(1), 2001, pp. 45-51

Authors: Szostak, MJ Kaur, P Amin, P Jacobs, SC Kyprianou, N
Citation: Mj. Szostak et al., Apoptosis and BCL-2 expression in prostate cancer: Significance in clinical outcome after brachytherapy, J UROL, 165(6), 2001, pp. 2126-2130

Authors: Bruckheimer, EM Kyprianou, N
Citation: Em. Bruckheimer et N. Kyprianou, Dihydrotestosterone enhances transforming growth factor-ss-induced apoptosis in hormone-sensitive prostate cancer cells, ENDOCRINOL, 142(6), 2001, pp. 2419-2426

Authors: Winter, RN Kramer, A Borkowski, A Kyprianou, N
Citation: Rn. Winter et al., Loss of caspase-1 and caspase-3 protein expression in human prostate cancer, CANCER RES, 61(3), 2001, pp. 1227-1232

Authors: Szostak, MJ Kyprianou, N
Citation: Mj. Szostak et N. Kyprianou, Radiation-induced apoptosis: Predictive and therapeutic significance in radiotherapy of prostate cancer (Review), ONCOL REP, 7(4), 2000, pp. 699-706

Authors: Bruckheimer, EM Kyprianou, N
Citation: Em. Bruckheimer et N. Kyprianou, Apoptosis in prostate carcinogenesis - A growth regulator and a therapeutic target, CELL TIS RE, 301(1), 2000, pp. 153-162

Authors: Kyprianou, N Chon, J Benning, CM
Citation: N. Kyprianou et al., Effects of alpha(1)-adrenoceptor (alpha(1)-AR) antagonists on cell proliferation and apoptosis in the prostate: Therapeutic implications in prostaticdisease, PROSTATE, 2000, pp. 42-46

Authors: Denis, LJ Behre, HE Bracke, M Griffiths, K Krieg, M Kyprianou, N Lee, C Mahler, CH Petritisch, P Prezioso, D Prins, GS Tunn, U Vermeulen, A
Citation: Lj. Denis et al., Estrogens and prostatic disease, PROSTATE, 45(2), 2000, pp. 87-100

Authors: Guo, YP Sigman, DB Borkowski, A Kyprianou, N
Citation: Yp. Guo et al., Racial differences in prostate cancer growth: Apoptosis and cell proliferation in Caucasian and African-American patients, PROSTATE, 42(2), 2000, pp. 130-136

Authors: Kyprianou, N Bruckheimer, EM Guo, Y
Citation: N. Kyprianou et al., Cell proliferation and apoptosis in prostate cancer: significance in disease progression and therapy, HIST HISTOP, 15(4), 2000, pp. 1211-1223

Authors: Kyprianou, N Benning, CM
Citation: N. Kyprianou et Cm. Benning, Suppression of human prostate cancer cell growth by alpha 1-adrenoceptor antagonists doxazosin and terazosin via induction of apoptosis, CANCER RES, 60(16), 2000, pp. 4550-4555

Authors: Kyprianou, N
Citation: N. Kyprianou, Activation of TGF-beta signalling in human prostate cancer cells suppresses tumorigenicity via deregulation of cell cycle progression and induction of caspase-1 mediated apoptosis: significance in prostate tumorigenesis, PROSTATE C, 2, 1999, pp. S18-S18

Authors: Chon, JK Borkowski, A Partin, AW Isaacs, JT Jacobs, SC Kyprianou, N
Citation: Jk. Chon et al., alpha(1)-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia, J UROL, 161(6), 1999, pp. 2002-2008

Authors: Guo, YP Kyprianou, N
Citation: Yp. Guo et N. Kyprianou, Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis, CANCER RES, 59(6), 1999, pp. 1366-1371

Authors: Del Pizzo, JJ Borkowski, A Jacobs, SC Kyprianou, N
Citation: Jj. Del Pizzo et al., Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival, AM J PATH, 155(4), 1999, pp. 1129-1136
Risultati: 1-17 |